![]() Oricell Therapeutics OriCell Therapeutics (原启生物科技(上海)有限责任公司) is a biotech company specializing in tumor immunotherapy drug development. | ![]() NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. | ![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ![]() Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. | |
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 1994 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Shanghai, CN HQ | Locations Wilmington, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations Cambridge, US HQ |
Employees | Employees 235% increase | Employees 403% increase | Employees 8174% decrease | Employees 688% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 96.2 m | Valuation ($) 176.4 m |
Financial | ||||
Net income | Net income N/A | Net income N/A | Net income ($3.1m) (FY, 2025) | Net income $4.8m (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 120m (almost 4 years ago) | Latest funding round $ 200m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 162m | Total funding raised $ 200m | Total funding raised $ 171.1m | Total funding raised N/A |

NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View company
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View company